Fludarabine
Hemoglobinuria, Paroxysmal Nocturnal (PNH)
St. Jude Children's Research HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Hemoglobinuria, Paroxysmal Nocturnal (PNH) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Thiotepa Fred Hutchinson Cancer Center | Phase 3 | BB |
Muromonab-Cd3 St. Jude Children's Research Hospital | Phase 3 | BB |
Cyclophosphamide Roswell Park Cancer Institute | Phase 3 | BB |
Evomela Roswell Park Cancer Institute | Phase 3 | BB |
Fludarabine Fred Hutchinson Cancer Center | Phase 3 | BB |
View all 22 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →